Your browser doesn't support javascript.
loading
Characteristics of chemotherapy-induced diabetes mellitus in acute lymphoblastic leukemia patients / 浙江大学学报(英文版)(B辑:生物医学和生物技术)
Journal of Zhejiang University. Science. B ; (12): 740-744, 2020.
Artículo en Inglés | WPRIM | ID: wpr-1010552
ABSTRACT
Acute lymphocytic leukemia (ALL) is one of the most common malignancies, especially in young people. Combination chemotherapy for ALL typically includes corticosteroids (Kantarjian et al., 2000). Hyperglycemia is a well-recognized complication of corticosteroids, and chemotherapy-induced diabetes (CID) is not uncommon (27.5%-37.0%) during the treatment of ALL (Hsu et al., 2002; Weiser et al., 2004; Alves et al., 2007). Besides the effect of corticosteroids, potential factors triggering hyperglycemia in ALL also include direct infiltration of the pancreas by leukemia cells and β cell dysfunction induced by chemotherapeutic agents such as L-asparagine (Mohn et al., 2004).
Asunto(s)

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Factores de Edad / Diabetes Mellitus / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Límite: Adolescente / Adulto / Anciano / Femenino / Humanos / Masculino Idioma: Inglés Revista: Journal of Zhejiang University. Science. B Año: 2020 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Factores de Edad / Diabetes Mellitus / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Límite: Adolescente / Adulto / Anciano / Femenino / Humanos / Masculino Idioma: Inglés Revista: Journal of Zhejiang University. Science. B Año: 2020 Tipo del documento: Artículo